Transversus Abdominis Plane Block Versus Wound Infiltration for Postcesarean Analgesia
Postcesarean Analgesia
About this trial
This is an interventional treatment trial for Postcesarean Analgesia
Eligibility Criteria
Inclusion Criteria:
- American Society of Anesthesiologists physical status II
- Full-term singleton pregnancy
Exclusion Criteria:
- Age <19 or > 40 years
- Height <150 cm
- Weight <60 kg
- Body mass index ≥40 kg/m2
- Contraindications to spinal anesthesia (patient refusal, increased intracranial tension, coagulopathy, uncorrected hypovolemia)
- Hypersensitivity to any of the drugs used in the study
- Significant cardiovascular, renal, or hepatic disease
- Known fetal abnormalities
- Emergency situations
Sites / Locations
- Department of Anesthesia, Mansoura University Hospitals
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
Wound Infiltration
Transversus abdominis plane block
Cesarean delivery performed under spinal anesthesia (intrathecal bupivacaine 12.5 mg and intrathecal fentanyl 15 µg). At the end of surgery, 30 mL bupivacaine 0.25% will be injected subcutaneously in the surgical wound (15 mL on the upper and lower sides) by the obstetrician before skin suturing. Sham procedure will be performed after surgery. Standard analgesia (ketorolac and paracetamol) and fentanyl patient-controlled analgesia will be administered postoperatively.
Cesarean delivery performed under spinal anesthesia (intrathecal bupivacaine 12.5 mg and intrathecal fentanyl 15 µg). After completion of surgery, bilateral ultrasound-guided TAP block will be performed using 20 mL bupivacaine 0.25% on each side. Standard analgesia (ketorolac and paracetamol) and fentanyl patient-controlled analgesia will be administered postoperatively.